Search filters

List of works by Rikke Fredslund Andersen

A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

scientific article

Association between the expression of microRNAs and the response of patients with locally advanced rectal cancer to preoperative chemoradiotherapy

scientific article published on 9 May 2017

Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

scientific article published on 04 August 2017

Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer.

scientific article published on 17 June 2014

Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma.

scientific article

Circulating HOXA9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer

scientific article published on 20 December 2019

Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer

scientific article

Circulating microRNAs as biomarkers of adult Crohn's disease.

scientific article published in September 2015

Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy.

scientific article published on 24 October 2015

Controls to validate plasma samples for cell free DNA quantification.

scientific article published on 18 April 2015

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA).

scientific article

Delta tocotrienol in recurrent ovarian cancer. A phase II trial

scientific article published on 09 January 2019

EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.

scientific article published on 22 October 2009

Gemcitabine and capecitabine for heavily pre-treated metastatic colorectal cancer patients--a phase II and translational research study

Improved sensitivity of circulating tumor DNA measurement using short PCR amplicons.

scientific article published on 20 October 2014

Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer. ⬇️

scientific article

KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer

scientific article

Levels of cell-free DNA and plasma KRAS during treatment of advanced NSCLC.

scientific article published on 6 December 2013

MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.

scientific article

MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial

scientific article published on 06 August 2013

Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

scientific article published on 12 March 2018

NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer

scientific article published on 25 October 2019

Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers

scientific article published on 14 December 2019

Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment

scientific article published on 24 October 2018

Plasma HER2 amplification in cell-free DNA during neoadjuvant chemotherapy in breast cancer.

scientific article published on 12 March 2013

Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial

scientific article published on 27 September 2019

Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancer

scientific article published on 01 September 2012

Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab.

scientific article

Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab

scientific article

Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors

scientific article published on 01 July 2008

Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification.

scientific article published in January 2015

Quantification of microRNA in plasma using probe based TaqMan assays: is microRNA purification required?

scientific article published on 10 May 2019

Quantification of microRNA levels in plasma - Impact of preanalytical and analytical conditions

scientific article published on 19 July 2018

Quantitative analysis of vascular endothelial growth factor receptors 1 and 2 in colorectal cancer

scientific article published on 01 September 2009

Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.

scientific article published in July 2005

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

scientific article

Response to comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'.

scientific article published on 11 March 2014

Screening for circulating RAS/RAF mutations by multiplex digital PCR.

scientific article published on 12 May 2016

Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients.

scientific article

The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer

scientific article published on 11 November 2009

The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer.

scientific article published on 29 January 2009

The influence of tissue ischemia on biomarker expression in colorectal cancer.

scientific article published in July 2013

The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer

scientific article published on 02 February 2010

The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer ⬇️

scientific article published on December 6, 2011

The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer.

scientific article

The prognostic value of haplotypes in the vascular endothelial growth factor a gene in colorectal cancer

scientific article published on 28 June 2010

The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer ⬇️

scientific article

Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analyses

scientific article published on 13 November 2018

Paulina is supported by:

About Paulina

Help